Hiroshima G7 Global Health Task Force

2022–2023

In 2023, Japan hosts the G7 Summit in Hiroshima, the “City of Peace.” Ahead of the Summit, in July of 2022 JCIE established the Hiroshima G7 Global Health Task Force under the Executive Committee on Global Health and Human Security (Chairman: Keizo Takemi, Member of the House of Councillors; Executive Director: Akio Okawara, President and CEO, JCIE) to make recommendations to the Japanese government on the G7 agenda and concrete measures to be promoted for global health in the context of the rapidly changing global health architecture. Research teams were created to examine the three major themes, and the Task Force organized several international dialogues that engaged representatives from diverse sectors across G7 and non-G7 countries.

In April 2023, the Task Force released its recommendations and key action points for the 2023 G7. Through these efforts, the Task Force seeks to reaffirm Japan’s position in the ever-changing international community, identify areas where Japan should lead as the 2023 G7 chair, and explore specific measures to pursue even beyond the 2023 G7 Summit.

TASK FORCE NEWS

Hiroshima G7 global health task force follow-up initiative

Hiroshima G7 Global Health Follow-Up Initiative Kick-off Event: Reflections on the 2023 G7

June 27, 2023

|

Online
This webinar is a kick-off for the Hiroshima G7 Global Health Follow-up Initiative, and aims to reflect on the 2023 G7 communique and past G7 commitments….
JCIE and Hiroshima G7 Task Force Members meet with Seiji Kihara and Keizo Takemi for the launch of the Task Force's Recommendations to the G7

Hiroshima G7 Global Health Task Force Recommendations for the G7 Meetings in Japan

April 2023

|

This report, available in both English and Japanese, outlines the Task Force for Promoting Pharmaceutical and Medical Device Regulatory Harmonization in Asia’s strategy recommendations for a COVID-19 emergency response. …
Hiroshima G7 Global Health Task Force Recommendations for Promoting Global Solidarity Towards a More Resilient Health System

Hiroshima G7 Task Force: Recommendations for Promoting Global Solidarity Towards a More Resilient Health System

April 5, 2023

|

Online
JCIE co-hosted a special webinar with Pandemic Action Network (PAN), and the University of Tokyo’s Institute for Future Initiatives to discuss JCIE’s Hiroshima G7 Global Health Task Force recommendations for Japan’s G7 global health agenda….
Hiroshima G7 Global Health Task Force

JCIE's Hiroshima G7 Global Health Task Force Publishes Comments in the Lancet Ahead of G7 Meetings

April 4, 2023

|

The Lancet published a comment from the Hiroshima G7 Global Health Task Force, outlining the Task Force’s recommendations for tackling some of the main challenges in global health: advancing the resilience of health systems to address public health emergencies and enhancing global…
Hiroshima G7 Global Health Task Force dialogue

Hiroshima G7 Global Health Task Force Dialogue Series

February 1–10, 2023

|

Online
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health. This roundtable was an opportunity for…
IMG-5511

Hiroshima G7 Global Health Taskforce Roundtable Discussion

November 30, 2022

|

Washington DC
In 2023, Japan will host the G7 Summit in Hiroshima. JCIE has established a Hiroshima G7 Global Health Task Force to make recommendations to the Japanese government on the G7 agenda for global health. This roundtable was an opportunity for…
German-Japan global health dialogue cover image

The Roles of Germany and Japan in Global Health IV

October 19, 2022

|

Berlin and Online
Japanese and German politicians, policy experts, business leaders, and global health experts participated in a hybrid forum to utilize the countries’ bilateral relationship to discuss key issues in global health and how to pass the G7 presidency baton from Germany…
G7,Summit,Or,Meeting,Concept.,Row,From,Flags,Of,Members

Launch of the G7 Global Health Task Force

August 10, 2022

|

Japan
Ahead of the G7 Summit, JCIE has established the 2023 G7 Global Health Task Force under the Executive Committee on Global Health and Human Security to make recommendations to the Japanese government on the G7 agenda and concrete measures to…
Background

The 2023 G7 Summit will be held on May 19–21 in Hiroshima, Japan. The invasion of Ukraine by Russia, a permanent member of the UN Security Council, has raised many issues for the current international framework, and Japan must rebuild its diplomatic power and consider how it can contribute to the realization of a peaceful and stable international community. Global health is an important theme that could become a key pillar as Japan reestablishes its diplomatic capacity.

In the field of global health, the global spread of the COVID-19 pandemic has made the link between health and society, the economy, and security even clearer than before, and beyond just the health sector, it has indicated the need for commitment and leadership at the head-of-state level. In addition, it has spurred an active discussion in the international community on how to enhance the response for and preparedness to health crises, including pandemics.

On May 24, 2022, Japan announced its Global Health Strategy. The strategy includes the following as its major goals: (1) to contribute to developing a resilient global health architecture for prevention, preparedness, and response (PPR) to public health crises, including pandemics; and (2) to realize human security by accelerating the efforts to achieve more resilient, equitable, and sustainable Universal Health Coverage (UHC), a necessary goal in the new era post-COVID. A summary of the Global Health Strategy strategy can be found here.

The “G7 Ise-Shima Vision for Global Health,” which was approved during the 2016 summit  hosted by Japan, identified achieving UHC and responding to health crises as the “two wheels of the cart.” This policy framework has become even more relevant now in light of the COVID-19 experience. Moreover, given Japan’s advocacy for sustainable UHC and its role in placing population aging on the G20 agenda for the first time at the 2019 G20 Osaka Summit, supporting preparedness that reflects the world’s demographic shifts and changes in epidemiological structures is another issue that Japan should pursue.

This Task Force is being convened by JCIE’s Executive Committee on Global Health and Human Securitya unique public-private platform established in 2007 that facilitates the Japanese government’s policymaking on global health and public-private collaboration in that field. The committee similarly convened a working group to make recommendations in the lead-up to the 2016 G7 Summit.  

MAIN THEMES
1.  100 Days Mission and Access & Delivery (100 Days Mission PLUS)
2.  Resilient, Equitable, and Sustainable UHC
3. Global Health Architecture Development

Director

HIDEAKI SHIROYAMA, Professor, Graduate School of Public Policy and Graduate School of Law and Politics, University of Tokyo; Director, Institute for Future Initiatives, The University of Tokyo

Deputy Directors 

HIROKI NAKATANI, Visiting Professor, Faculty of Medicine, Keio University; Advisor for International Affairs, Ministry of Health, Labour and Welfare (MHLW); Member, WHO Executive Board

OSAMU KUNII, Executive Director and CEO, GHIT Fund (Chair, 100 Days Mission PLUS )

KAYO TAKUMA, Professor, Faculty of Law, Tokyo Metropolitan University (Chair, Global Health Architecture Group)

Japan Working Group 

KEISHI ABE, Senior Fellow, Institute for Policy Studies, National Graduate Institute for Policy Studies

SARAH KRULL ABE, Section Head, Division of Prevention, National Cancer Center Institute for Cancer Control (Scientific Coordinator)

TAKANORI FUJITA, Project Lead of Healthcare Data Project, World Economics Forum Centre for the Forth Industrial Revolution Japan

CHIEKO IKEDA, Director General, Bureau of International Health Cooperation, National Center for Global Health and Medicine (UHC Chair)

MASAKI INABA, Co-Chair, Africa Japan Forum; Chair, Japan CSO Network on Global Health

KAZUAKI JINDAI, Assistant Professor, Graduate School of Medicine, Tohoku University

MIHOKO KASHIWAKURA, Head of Japan, Bill & Melinda Gates Foundation

NAOKI KONDO, Professor, Department of Social Epidemiology, Graduate School of Medicine, Kyoto University

MAKIKO MATSUO, Project Associate Professor, Graduate School of Public Policy, The University of Tokyo

YOSHITAKA NISHINO, Research Associate, JCIE/Japan (Assistant Coordinator)

SHUHEI NOMURA, Associate Professor, Department of Health Policy and Management, Keio University School of Medicine

HARUKA SAKAMOTO, Associate Professor, Department of Hygiene and Public Health, Tokyo Women’s Medical University

TOMOKO SUZUKI, Chief Program Officer, JCIE/Japan (Chief Coordinator)

AYAKO TAKEMI, Associate Professor, Research Center for Advanced Science and Technology, The University of Tokyo

※We are also requesting cooperation from relevant ministries and agencies

International Advisors

LAV AGARWAL, Additional Secretary, Ministry of Health and Family Welfare, Government of India

MANICA BALASEGARAM, Executive Director, GARDP

SETH BERKLEY, CEO, Gavi, the Vaccine Alliance

JOE CERRELL, Managing Director for Europe, the Middle East, and East Asia (EMEEA), Bill & Melinda Gates Foundation

AWA MARIE COLL-SECK, Minister of State to the President of the Republic of Senegal

THOMAS B. CUENI, Director General, International Federation of Pharmaceutical Manufacturers & Association (IFPMA)

MANDEEP DHALIWAL, Director, HIV, Health and Development Group, Bureau for Policy and Programme Support, United Nations Development Programme (UNDP)

ALAN DONNELLY, Conenor, G20 Health & Development Partnership

PHILIPPE DUNETON, Executive Director, Unitaid

MARK DYBUL, Faculty Co-Director, Center for Global Health and Quality, and Professor, Department of Medicine, Georgetown University Medical Center

VICTOR DZAU, President, National Academy of Medicine (NAM), USA

JEREMY FARRAR, Director, Wellcome Trust

RICHARD HATCHETT, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)

RICHARD HORTON, Editor-in-Chief, the Lancet

ABOUBACAR KAMPO, Director of Health, Programme Group, United Nations Children’s Fund (UNICEF)

NATALIA KANEM, Executive Director, United Nations Population Fund (UNFPA)

ILONA KICKBUSCH, Founder, Global Health Centre at Graduate Institute of International & Development Studies in Geneva

JUSTIN KOONIN, Co-chair, Steering Committee, UHC2030

ROSEMARY MBURU, Executive Director, WACi Health, Kenya

KHUAT THI HAI OANH, Executive Director, Center for Supporting Community Development Initiatives, Vietnam

FRANCIS GERVASE OMASWA, Executive Director, African Centre for Global Health and Social Transformation

SCOTT PENDERGAST, Director, Health Emergencies Strategy, Programmes and Partnerships, World Health Organization (WHO)

PETER PIOT, Special Advisor on COVID-19 to the President, EU Chief Scientific Advisor Epidemics, Cabinet of Ursula Von Der Leyen, President of the European Commission

MICHAEL R. REICH, Takemi Professor of International Health Policy, Emeritus, Harvard T.H. Chan School of Public Health

CATHERINE RUSSELL, Executive Director, UNICEF

PETER SANDS, Executive Director, the Global Fund to Fight AIDS, Tuberculosis and Malaria

DIAH SATYANI SAMINARSIH, Founder and CEO, Center for Indonesia’s Strategic Development Initiatives (CISDI); Former Senior Advisor on Gender and Youth to WHO Director General

KENJI SHIBUYA, Research Director, The Tokyo Foundation for Policy Research 

JUAN PABLO URIBE, Global Director for Health Nutrition and Population, World Bank; Director, Global Financing Facility for Women, Children and Adolescents (GFF)

PATRICK VALLANCE, Government Chief Scientific Adviser, UK

WALAIPORN PATCHARANARUMOL, Director, Global Health Division, Ministry of Public Health; Secretary General, IHPP Foundation

NAOKO YAMAMOTO, Appointed Professor, International University of Health and Welfare

ROBERT YATES, Director, Global Health Programme; Executive Director, Centre for Universal Health, Chatham House

The Task Force is grateful for the input of all those who participated in our in-person and online events, whose names can be found on these pages:
Many thanks also to the following for their insights:
  • Damiano De Felice, Director of Development and External Engagement, CARB-X
  • Global Health Security Consortium
  • Heulwen Philpot, Head of Secretariat, International Pandemic Preparedness Secretariat (IPPS)
  • Soumya Swaminathan, former WHO Chief Scientist
  • The Joint United Nations Programme on HIV/AIDS (UNAIDS)
  • World Economic Forum Regional Vaccine Manufacturing Collaborative
  • WHO Hub for Pandemic and Epidemic Intelligence (the WHO Pandemic Hub)